RG-003

N/A

Report date: 2025/04/30 13:55:03
NME

Base Information

Drug NameRG-003
Drug Alias NameRG003RG-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsPrimary Myelofibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRudong Ringene Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRudong Ringene Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Myelofibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A